(603139)"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 603139 · · 15 pages · Chinese
Shaanxi Kanghui Pharmaceutical Co., Ltd. on 6ix
Earlier from Shaanxi Kanghui Pharmaceutical
- (603139)"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 6th Extraordinary General Meeting in 2026
- (603139)"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Progress in Providing Guarantee for Wholly-owned Subsidiary
- (603139)"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Notice on Convening the 6th Extraordinary General Meeting in 2026
- (603139)"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Supplementing the Estimated Guarantee Amount for Controlled Subsidiaries
- (603139)"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 17th Meeting of the 6th Board of Directors
Later from Shaanxi Kanghui Pharmaceutical
- (603139)"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Disposal of Assets
- (603139)"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Establishment of Wholly-owned Subsidiary
- (603139)"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Progress of the Computing Power Service Contract of Wholly-owned Subsidiary
- (603139)"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 19th Meeting of the 6th Board of Directors
Follow Shaanxi Kanghui Pharmaceutical into a list and get an email when it puts out news.
Follow Shaanxi Kanghui Pharmaceutical